ARMI will attend SynBioBeta 2026, highlighting the intersection of synthetic biology and regenerative manufacturing, with Dean Kamen featured among key innovators.
ARMI will attend RAPID + TCT 2026 to explore the intersection of additive manufacturing and biomanufacturing, driving innovation in regenerative healthcare solutions.
ARMI sponsors Rockwell Automation Fair 2025 to explore smart manufacturing technologies and digital transformation in biomanufacturing and regenerative medicine.
BioFabUSA will exhibit and present at DMC 2026, sharing how scalable biomanufacturing can strengthen U.S. defense capabilities and support resilient manufacturing systems.
ARMI | BioFabUSA will attend Meeting on the Mesa 2025, one of the premier partnering events for the cell and gene therapy sector, taking place October 6–8 in Phoenix, AZ.
ARMI joins Wicked STEM 2025 with hands-on exhibits and a keynote, introducing students to careers in biomanufacturing and the future of regenerative medicine.
ARMI | BioFabUSA will participate in the Thunder Over NH STEM Open House on September 6–7, 2025 at Pease Air National Guard Base in Newington, NH. As part of the
Hosted by the BioFab Startup Lab, the 2025 BioFab Investment Summit connects early-stage companies with investors and partners driving regenerative medicine forward.
ARMI will present at TERMIS 2025, highlighting cutting-edge regenerative medicine research and its role in scaling biomanufacturing through national collaboration.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
